CD34 and plasma cell myeloma: We determined that approximately 75% of CD34+ mobilized peripheral blood progenitor cells from myeloma patients en route to SCT co-expressed CD38 (Fig. 1a, b), and then sought to determine the number of CD38 molecules per CD34+ cell.